Clinical observation of the effect of thymosin combined with biapenem in the treatment of severe lower respiratory tract infection of gram negative bacilli
10.3760/cma.j.issn.1008-6706.2012.21.021
- VernacularTitle:胸腺肽联合比阿培南治疗革兰阴性杆菌重症下呼吸道感染疗效观察
- Author:
Xiangjian LU
;
Lipeng GAO
;
Chuanguo ZHANG
- Publication Type:Journal Article
- Keywords:
Respiratory tract infections;
Gram-negative bacteria;
Thymus extracts;
Biapenem;
Treatment outcome
- From:
Chinese Journal of Primary Medicine and Pharmacy
2012;19(21):3240-3241
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the effect and safety of thymosin combined with biapenem in the treatment of severe lower respiratory tract infection of gram negative bacilli.Methods 54 patients with severe lower respiratory tract infection of gram negative bacilli were randomly divided into study group (group A) and control group (group B),group A was treated with thymosin and biapenem,group B biapenem.All patients were treated for 7 ～ 14 days in a course.The clinical effect,treatment time of biapenem,the bacterial clearance rate and adverse drug reaction betweeen two groups were compared.Results The clinical effective rate of group A and B were 84.6％ and 82.1％,respectively,there was no statistical difference (P ＞ 0.05).Treatment time of biapenem in group A and B was (8.2 ±3.4) days and (13.2 ± 3.6) days,respectively,there was statistical difference (P ＜ 0.05).The bacterial clearance rate of group A and B were 86.7％ and 80.7％,respectively,there was no statistical difference between two groups (P ＞ 0.05).Conclusion The treatment time of thymosin combined with biapenem treatment of gram-negative bacilli severe respiratory tract infection was shorter than that of biapenem alone treatment,and it was safe,effective,and worthy of ciinical application.
